This study demonstrates that androgen deprivation therapy (ADT) significantly reduces TMPRSS2 expression in the lung tissue of prostate cancer patients, with direct AR antagonists exerting the most pronounced effect. Here, TMPRSS2 is linked to Familial prostate cancer.